drugset / Trial / NCT05141422
A Drug-drug Interaction Study of SHR2150 on Healthy Chinese Volunteers
NaSingle-groupOpen-labelBasic science
Summary
The study is a single-centre, open-label, fixed-sequence, self-controlled clinical trial. It is planned to enroll 20 healthy adult subjects. Subjects will take SHR2150 on Day 1 and Day 21, and take efavirenz from Day 7 to Day 26.
Timeline
- Start
- 2021-12-13
- Primary completion
- 2022-01-15
- Completion
- 2022-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efavirenz | Other / unclassified | — | — |
| Subject | SHR2150 | Small molecule | — | — |